H.R.3616 - Inflammatory Bowel Disease Research Act109th Congress (2005-2006)
|Sponsor:||Rep. Kelly, Sue W. [R-NY-19] (Introduced 07/29/2005)|
|Committees:||House - Energy and Commerce|
|Latest Action:||11/10/2005 Sponsor introductory remarks on measure. (CR E2334) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3616 — 109th Congress (2005-2006)All Information (Except Text)
Introduced in House (07/29/2005)
Inflammatory Bowel Disease Research Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; and (6) other research initiatives identified in specified documents.
Requires the Director of the Centers for Disease Control and Prevention (CDC) to prepare a National Inflammatory Bowel Disease Action Plan to: (1) address the burden of inflammatory bowel disease in both adult and pediatric populations; (2) address strategies for determining the prevalence of the disease in the United States and the unique demographic characteristics of the patient community; (3) focus on strategies for increasing awareness about the disease within the general public and the health care community; and (4) address mechanisms designed to prevent the progression of the disease and the development of complications.